Skip to content

Clinical implication of atrial fibrillation detection using elctrocardiogram patch or smartphone-based device in patients with cryptogenic stroke

Clinical implication of atrial fibrillation detection using wearable device in patients with cryptoge nic stroke - The comparison between short-term continuous patch and long-term discontinuou s monitoring

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0005592
Enrollment
600
Registered
2020-11-12
Start date
2020-11-18
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : 1) Active Comparator: Conventional Holter Monitoring Group Holter monitoring is performed for 24 hours each at 1, 3, and 12 months after the diagnosis of stroke, and if atrial fibrill

Sponsors

Ewha Womans University Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All patients, except those with atrial fibrillation, who first came to our neurology department after IRB approval for stroke or transient ischemic attack.

Exclusion criteria

Exclusion criteria: - Excluding patients who have previously had atrial fibrillation or whose atrial fibrillation was first detected on the first surface electrocardiogram - Excluding patients who cannot use the Kardia Mobile system by themselves or with the help of others. - Excludes patients with artificial pacemakers (pacemakers), implantable defibrillators, or other implantable electrical devices. - Excluding pregnant women and lactating women. - Excluding cases with current symptoms or history of skin cancer, rash, skin disease, keloid or injury.

Design outcomes

Primary

MeasureTime frame
Compare atrial fibrillation detection rates of each arms

Secondary

MeasureTime frame
Major adverse cardiovascular and cerebrovascular event;Change from antiplatelet therapy to anticoagulants following AF detection;Major bleeding;Re-admission;All-cause death

Countries

Korea, Republic of

Contacts

Public ContactSoomi Jung

Ewha Womans University Medical Center

hihello2222@naver.com+82-2-2650-5865

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: May 22, 2026